Diagnostic testing to identify persons infected with severe acute respiratory syndrome–related
coronavirus 2 (SARS-CoV-2) infection is central to control the global pandemic of COVID-…

Background Our understanding of the global scale of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection remains incomplete: Routine surveillance data …

To the Editor: Neuraminidase inhibitors (oseltamivir and zanamivir) are recommended for
treatment of severe illness caused by the 2009 pandemic influenza A (H1N1) virus, and their …

Background Many studies report the seroprevalence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibodies. We aimed to synthesize seroprevalence data to …

Background: The role of remdesivir in the treatment of patients in hospital with COVID-19
remains ill defined in a global context. The World Health Organization Solidarity randomized …

Background: Rapid and accurate influenza diagnostics can improve patient care. Purpose:
To summarize and compare accuracy of traditional rapid influenza diagnostic tests (RIDTs), …

Accurate serologic tests to detect host antibodies to severe acute respiratory syndrome–related
coronavirus 2 (SARS-CoV-2) will be critical for the public health response to the …

Background Respiratory syncytial virus (RSV) infection is an important cause of pneumonia
mortality in young children. However, clinical data for fatal RSV infection are scarce. We …

Respiratory syncytial virus (RSV) rapid antigen detection tests (RADT) are extensively used
in clinical laboratories. We performed a systematic review and meta-analysis to evaluate the …

Background. Human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) are
leading pediatric pathogens. However, risk factors for severe hMPV disease remain unknown. …